[PDF][PDF] 口服新型冠状病毒肺炎治疗新药——莫努匹韦
赵锦霞， 黄婧， 黄琳 - 临床药物治疗杂志, 2022 - lcywzlzz.com
… granted emergency approval for molnupiravir for the treatment of non-hospitalized adults with
mild or moderate COVID-19 on 23 … A phase 2a clinical trial of molnupiravir in patients with …
mild or moderate COVID-19 on 23 … A phase 2a clinical trial of molnupiravir in patients with …
[PDF][PDF] 新型冠状病毒肺炎的抗病毒治疗进展
石浩川， 潘蕾 - 中国现代医药杂志, 2024 - zgxdyyzz.com.cn
… for treatment of non-hospitalized patients with COVID-19:a … for the treatment of hospitalised
adults with COVID-19(COV-… Molnupiravir plus usual care versus usual care alone as …
adults with COVID-19(COV-… Molnupiravir plus usual care versus usual care alone as …
[HTML][HTML] Acupoint stimulation for long COVID: A promising intervention: 穴位刺激治疗长新冠: 一种有前景的干预措施
BW Feng, PJ Rong - World Journal of Acupuncture-Moxibustion - ncbi.nlm.nih.gov
… is effective in treating the various phases of COVID-19. Previous … Several antiviral drugs,
such as remdesivir, molnupiravir, and … This study provides a theoretical basis for acupuncture to …
such as remdesivir, molnupiravir, and … This study provides a theoretical basis for acupuncture to …
3C 样蛋白酶抑制剂博福特韦的研发实践和策略
谢东， 胡敏， 姚成 - 药学进展, 2023 - pps.cpu.edu.cn
… 病毒(SARS-CoV-2,以下简称新冠病毒)感染 (COVID-19).团队开发了… 而莫诺拉韦(molnupiravir)的
Ⅱa 期研究中进一步 采用了传染性… for high-risk, nonhospitalized adults with COVID-19[J]. N …
Ⅱa 期研究中进一步 采用了传染性… for high-risk, nonhospitalized adults with COVID-19[J]. N …
[HTML][HTML] 湖南省首例Paxlovid 治疗新型冠状病毒奥密克戎BA. 5 变异株复阳病例报道
陈美平， 郭婷， 周志国， 陈东， 周海波 - Journal of Central South …, 2022 - ncbi.nlm.nih.gov
… (COVID-19) patient who was cured by oral administration of nirmatrelvir/ritonavir (Paxlovid).
The patient was treated … However, it is necessary to further study the mechanism that may …
The patient was treated … However, it is necessary to further study the mechanism that may …
新型冠状病毒奥密克戎变异株的最新研究进展.
洪子强， 盛燕楠， 金大成， 白向豆… - China Tropical …, 2022 - search.ebscohost.com
… 药物Molnupiravir 已获FDA 的批准,成为 首个用于COVID-19的… of SARS-CoV-2 infection:
retrospective cohort study[J]. BMJ, … for high-risk, nonhospitalized adults with covid-19[J]. N Engl J …
retrospective cohort study[J]. BMJ, … for high-risk, nonhospitalized adults with covid-19[J]. N Engl J …
[PDF][PDF] 奈玛特韦片/利托那韦片安全性病例回顾及文献综述
安鹏姣， 刘鑫， 张波 - 临床药物治疗杂志, 2023 - lcywzlzz.com
… in the treatment of severe corona virus disease (COVID-19)… trelvir for high-risk,nonhospitalized
adults with covid-19[J]. N … antiCOVID-19 agents nirmatrelvir-ritonavir and molnupiravir[J]…
adults with covid-19[J]. N … antiCOVID-19 agents nirmatrelvir-ritonavir and molnupiravir[J]…